|Market Research A to Z | Company Profiles A to Z | Register | Contact Us | Shopping Basket|
|+44 (0) 203 086 8600 Call us on|
The brachytherapy devices market was worth a value of $268.2 million in 2011, and has been forecast to increase at a compound annual growth rate (CAGR) of 3% through to 2018, to be worth a total market value of $322 million.
Growth within the brachytherapy devices market is expected to be driven by the increasing incidence of cancer, improved efficiency, shorter time required for treatment, and cost effectiveness.
Brachytherapy is a type of radiation therapy used for the treatment of cancer, and involves placing a radioactive material inside or near the tumour. This is also known as internal radiation therapy, and allows the physician to treat a small area with a higher dose of radiation in a shorter time.
Brachytherapy is a highly effective, outpatient procedure that is easily customizable to patients' individual needs, and offers many benefits to the increasing numbers of patients opting for non-invasive treatment option.
The brachytherapy devices market is expected to experience high uptake in emerging economies like India, China, and Brazil. Moreover, extending applications of this technique to other body sites is expected to drive this market temporarily in the near future.
Oncura is the largest player in the brachytherapy devices market with a 29% share followed by CR Bard who controls a 26% market share. Ibt Bebig has a 12% market share, and is the largest player in Europe with a market share of nearly 40%.
For more information on the brachytherapy devices market, see the latest research: Brachytherapy Devices Market Report
Follow us on Twitter @CandMResearch
Free Research Support: Let us do the work for you and find information from public and private sources of information. Contact us now and we can save you time and money.......Free Research Support
Use our skills and global network of researchers and consultants to help find and source the business information you need.
Contact us now on 00 44 (0) 203 0868600 or "enquiries @ companiesandmarkets.com" to discuss you requirements and we can provide you with a research solution at suprisingly efficient rates and timelines.
Sometimes we can even find the information you require for free.
We are offering our clients substantial savings on the best research available during September. Please contact us either via email or by calling our team to discuss your specific research needs on Tel: 00 44 (0) 203 0868600.